News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Charles Gillham: The first insertion within the HSE of a rectal spacer has taken place in SLRON
Photo from Charles Gillham/LinkedIn
Sep 8, 2024, 18:44

Charles Gillham: The first insertion within the HSE of a rectal spacer has taken place in SLRON

Charles Gillham posted on LinkedIn:

“Delighted that the first insertion within the HSE of a rectal spacer (SpacerOAR) has taken place in the St Luke’s Radiation Oncology Network.

This technology aims to reduce longterm rectal damage from prostate radiotherapy.

Huge thanks to the support of the NCCP and Boston Scientific.”

Charles Gillham: The first insertion within the HSE of a rectal spacer has taken place in SLRON

Source: Charles Gillham/LinkedIn

Charles Gillham is a radiation oncologist at St. James Hospital. He specialises in Radiotherapy for benign thyroid disease, gynaecology, ano-rectal, haematological cancers and sarcoma. Dr Gillham is a graduate of University College London (1994) and following an MD at Trinity College Dublin.

Boston Scientific cancer Charles Gillham HSE NCCP OncoDaily Oncology SLRON SpacerOAR St Luke’s Radiation Oncology Network
Special Coverage
Career
Apr 24, 2025, 21:39
Triparna Sen: I am thrilled and humbled to be nominated as a candidate for the IASLC Board of Directors
Blog
Apr 24, 2025, 21:05
Liz O’Riordan: 25 things I wish I had known before I got breast cancer
Blog
Apr 24, 2025, 20:53
Signing Ceremony of MoU Between Doha University for Science and Technology and Qatar Cancer Society
Blog
Apr 24, 2025, 20:40
Yan Leyfman: How AI is transforming cancer care - from improving diagnosis to reducing disparities
Insight
Apr 24, 2025, 20:28
Fernando Campos: We revealed a harsh Brazilian reality in Sarcoma Study
Insight
Apr 24, 2025, 19:38
George Vlachogiannis: Black patients were less likely to receive nephrectomy compared to non-Hispanic White patients
Blog
Apr 24, 2025, 18:30
Paolo Tarantino: Recent ADCs took a median time of 7 years from clinical introduction to approval
Blog
Apr 24, 2025, 17:56
Milestones from Philippine Cervical Cancer Elimination Operational Plan Workshop - APAC Women's Cancer Coalition
Blog
Apr 24, 2025, 17:55
Julie S. Torode: Attending my first ever AACR conference this week - long over due
Blog
Apr 24, 2025, 17:41
The Ohio State’s James Cancer Hospital and Solove Research Institute Welcomes Dr. Kimryn Rathmell as New CEO
Blog
Apr 24, 2025, 17:36
Bishal Gyawali: WHO EML working group discussion on checkpoint inhibitors for solid cancers
Blog
Apr 24, 2025, 17:27
Shane Jacobson: I had the chance to celebrate Dave Coulier being cancer free and now an Ambassador for the V Foundation